Physician profile
Jesal V Popat
NPI 1215256920
$205,591.78
in general payments reported to CMS, 2019-2025
47 companies · $71K in 2025
The $71K reported for 2025 was more than what 98% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,721 · 2020: $1,591 · 2021: $2,723 · 2022: $20K · 2023: $64K · 2024: $43K · 2025: $71K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $152K · Travel and Lodging: $13K · Food and Beverage: $11K · Consulting Fee: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $151,780.00 |
| Travel and Lodging | $13,328.46 |
| Food and Beverage | $11,308.80 |
| Consulting Fee | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $187,609.74 | 2021-2025 | Camzyos, Eliquis |
| Medtronic, INC. | $4,236.77 | 2021-2025 | Linq II, Reveal Linq, Onyx Frontier |
| Biotronik INC. | $2,134.23 | 2019-2024 | Amvia Edge |
| Novartis Pharmaceuticals Corporation | $1,374.84 | 2019-2025 | |
| Penumbra, INC. | $1,346.20 | 2019-2022 | |
| Medtronic Vascular, INC. | $998.29 | 2019-2020 | |
| Amgen INC. | $960.80 | 2019-2025 | Repatha, Repatha |
| Abbott Laboratories | $845.19 | 2019-2023 | Mitraclip, Aveir |
| Janssen Pharmaceuticals, INC | $620.93 | 2019-2024 | Xarelto |
| Esperion Therapeutics, INC. | $548.60 | 2020-2025 | Nexletol |
| Boston Scientific Corporation | $536.17 | 2019-2025 | Farapulse, Watchman Flx, Rotablator Rotational Atherectomy System Console Kit |
| Pfizer INC. | $341.46 | 2019-2025 | |
| Astrazeneca Pharmaceuticals Lp | $334.45 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $308.18 | 2019-2025 | Lifevest |
| Alnylam Pharmaceuticals INC. | $276.93 | 2025 | Onpattro, Amvuttra |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $259.75 | 2021-2025 | Ozempic, Wegovy |
| Merck Sharp & Dohme LLC | $250.37 | 2021-2025 | Verquvo |
| Cvrx, INC. | $242.32 | 2021-2025 | Barostim Neo System |
| Amarin Pharma, INC. | $235.43 | 2019-2021 | |
| Irhythm Technologies, INC. | $224.06 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| Lexicon Pharmaceuticals, INC. | $167.01 | 2023-2024 | Inpefa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $158.15 | 2020-2022 | |
| Abiomed | $154.63 | 2022-2025 | |
| Impulse Dynamics (USA) INC. | $146.09 | 2023 | Optimizer |
| Regeneron Healthcare Solutions, INC. | $129.12 | 2019-2024 | Evkeeza, Praluent |
| Sanofi-Aventis U.S. LLC | $122.45 | 2019-2023 | |
| Philips North America LLC | $119.62 | 2022-2024 | (Ck7) Extended Holter |
| Teleflex LLC | $106.15 | 2022 | |
| Biosense Webster, INC. | $102.73 | 2019 | |
| Siemens Medical Solutions USA, INC. | $78.44 | 2024 | Artis Icono Floor |
| Scpharmaceuticals INC. | $75.88 | 2024-2025 | |
| Kestra Medical Technology Services, INC. | $71.55 | 2022-2023 | Assure Wcd |
| Bardy Diagnostics, INC. | $65.00 | 2020-2021 | |
| Edwards Lifesciences Corporation | $55.14 | 2019-2020 | |
| Kiniksa Pharmaceuticals, Ltd. | $48.60 | 2021-2023 | Arcalyst |
| Chiesi USA, INC. | $46.31 | 2019-2024 | Juxtapid |
| Kiniksa Pharmaceuticals International, Plc | $41.77 | 2024 | Arcalyst |
| Glaxosmithkline, LLC. | $29.46 | 2025 | Arexvy, Shingrix |
| Angiodynamics, INC. | $26.98 | 2022 | |
| Atricure, INC. | $26.15 | 2025 | Atriclip Laa Exclusion System |
| Nuwellis, INC. | $25.99 | 2025 | Aquadex Smartflow Console |
| Shockwave Medical, INC | $23.30 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Actelion Pharmaceuticals US, INC. | $20.21 | 2022 | |
| Preventice Services, LLC | $18.79 | 2020 | |
| Csl Behring | $17.33 | 2019 | |
| Celgene Corporation | $15.48 | 2024 | |
| Kowa Pharmaceuticals America, INC. | $14.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jesal Popat listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.